We report a rare case of cervical cancer with duodenal obstruction accompanied by obstructive symptoms, which was treated using duodenal stenting. A 48-year-old woman was diagnosed with stage IV cervical cancer (according to the International Federation of Gynecology and Obstetrics staging system), which had invaded the vagina, the uterine body, and the external iliac and common iliac lymph nodes. Endoscopy showed an encircling mass with erythematous mucosa and luminal narrowing in the second and third portions of the duodenum, which prevented the endoscope from advancing. We placed an uncovered stent in the duodenum, which ameliorated abdominal discomfort, nausea, and vomiting, and simultaneously performed a biopsy. Endoscopic stent insertion appears to be the most effective treatment for duodenal obstruction in patients with advanced cancer. (Korean J Helicobacter Up Gastrointest Res 2012;12:128-131)
INTRODUCTION

Malignant duodenal obstruction occurs in approximately 20%
of patients with primary pancreatic, gastric, or duodenal carcinomas. However, duodenal obstruction in patients with cervical cancer is rare. Although early detection of cervical cancer reduces the chances of progression to the advanced stage of the disease, physicians should be aware of its varied presentations. We report a rare case of cervical cancer with duodenal obstruction accompanied by obstructive symptoms, which was treated by duodenal stenting.
CASE REPORT
A 48-year-old woman presented to a clinic with intermittent vaginal bleeding that had persisted for 3 months. Histological analysis indicated squamous cell carcinoma (SCC), and she was subsequently referred to the oncology department of the Chungnam University School of Medicine. The findings of MRI showed that the mass had invaded the external iliac and common iliac arteries as well as the uterine body and vagina.
We diagnosed the patient as having stage IV cervical cancer on the basis of the International Federation of Gynecology and Obstetrics staging system. About 3 months after the diagnosis, she was referred to the gastroenterology department because of CT scan ( Fig. 2A) . Endoscopy showed an encircling mass with erythematous mucosa and narrowing to a pinpoint in the second portion of the duodenum (Fig. 3A) , which prevented the endoscope from being advanced.
The patient reported persistent postprandial discomfort, anorexia, nausea, and intermittent vomiting. Therefore, endoscopic stent placement was performed to relieve her symptoms.
An uncovered, self-expandable metallic stent (diameter 20 mm, length 120 mm, HANAROSTENT; M.I. Tech Co., Seoul, Korea) was placed (Fig. 3B) , which ameliorated the postprandial discomfort and intermittent vomiting. There were no adverse events, such as abdominal pain or perforation. We si- (Fig. 4) .
Abdominal radiography confirmed that the stent was placed between the second and third portions of the duodenum (Fig.   5 ). Five days after stent placement, the patient was allowed oral intake of food.
DISCUSSION
Duodenal obstruction resulting from primary or metastatic cancer is a late occurrence in patients with advanced disease.
Obstructive symptoms, such as nausea, vomiting, and abdominal distention, as well as nutritional deficiencies, can lead to frequent hospitalization and high morbidity. available, 6 and palliative endoscopic stenting is being increasingly advocated and performed. 7 Endoscopic stent placement appears to be the safest and the most effective treatment for duodenal obstruction in patients with advanced cancer. Compared with palliative surgery, the placement of self-expandable metallic stents is associated with higher clinical success rates, less morbidity, shorter interval between the procedure and oral intake initiation, lower rate of delayed gastric emptying, and shorter hospital stay. 8, 9 A review of 32 publications published from 1992 to 2004 on metallic stent insertion for duodenal malignancies under fluoroscopic or endoscopic guidance showed that technical and clinical success was achieved in 97% and 87% of cases, respectively, with an overall complication rate of 28% (n=606). Moreover, metastasis to the small bowel is very rare. In a study on pretreatment laparotomy in 150 patients, 11 patients had intestinal lesions. Of these lesions, 8 were located in the small bowel (incidence of small bowel disease, 5.3%). 12 Duodenal lesions have also been reported, but rarely.
Cervical cancer can metastasize locally through lymphatic channels or a hematogenous route and generally remains restricted to the pelvic region. Cervical cancer can metastasize to the small bowel by direct invasion from the affected lymph nodes, primarily from the para-aortic or mesenteric nodes to the bowel serosa. 13 The lesions can cause bowel obstruction, bleeding, or abdominal pain, and poor oral intake, which can lead to dehydration, malnutrition, and poor quality of life.
14 In this case, abdominal CT scan showed lymph node metastasis in both the external iliac and common iliac lymph nodes and the left para-aortic nodes. Thus, metastasis, which causes duodenal obstruction, is thought to spread through lymph nodes.
The case reported here is unusual because of the rarity of duodenal invasion in patients with advanced cervical cancer.
And, obstructive symptoms, such as nausea and abdominal discomfort, improved after successful stent placement. In conclusion, the cause of malignant duodenal obstruction should be carefully determined from among the several potential causes and appropriate treatment should be administered.
